Selective RAR agonists for acne vulgaris: A narrative review.

Author: AbdelmaksoudAyman, GaladariHassan, GoldustMohamad, GrabbeStephan, GuptaMrinal, KaragaiahPriyanka, KassirMartin, KatsambasAndreas, LottiTorello, SonthaliaSidharth, WollinaUwe

Paper Details 
Original Abstract of the Article :
Acne vulgaris is a chronic disfiguring inflammatory disease of adolescents and adults affecting up to 90% of the population around the world. The sequence of etiopathogenesis in acne is not completely understood but involves abnormalities in sebum production, follicular plugging, proliferation of pr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/jocd.13340

データ提供:米国国立医学図書館(NLM)

Targeting Acne Vulgaris with Selective RAR Agonists

Acne vulgaris, a common skin condition that can be a source of frustration and self-consciousness, can be a challenging desert landscape to navigate. This review explores the potential of [selective RAR agonists], a class of drugs that target the retinoic acid receptor, as a treatment for acne vulgaris. The researchers discuss the underlying mechanisms of acne vulgaris and the potential benefits of selective RAR agonists in addressing these mechanisms.

A New Oasis for Acne Vulgaris Treatment

This review suggests that selective RAR agonists could be a promising new approach to treating acne vulgaris. The researchers highlight the potential of these drugs to address key aspects of acne pathogenesis, including sebum production, follicular plugging, and inflammation. Further research is needed to fully evaluate their effectiveness, but the potential benefits are promising.

Finding Clear Skin: A Journey to Confidence

This review provides a valuable overview of the potential of selective RAR agonists as a treatment for acne vulgaris. It offers a glimpse into the future of acne management, potentially paving the way for new and effective treatment options. It is a reminder that even in the challenging landscape of skin conditions, there can be oases of hope and effective treatment.

Dr. Camel's Conclusion

This review delves into the intriguing potential of selective RAR agonists as a treatment for acne vulgaris. It's a reminder that the pursuit of clear skin can be a journey, and like a camel navigating a vast desert, we must be patient and persistent in seeking new solutions. Selective RAR agonists may be a valuable oasis in our quest for healthy and radiant skin.

Date :
  1. Date Completed 2021-02-05
  2. Date Revised 2021-02-05
Further Info :

Pubmed ID

32100454

DOI: Digital Object Identifier

10.1111/jocd.13340

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.